Superworth

Thermo Fisher Scientific profit margin TMO

Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.

Net margin, 12 months
14.9%
Operating margin, 12 months
17.9%
Net margin on a year earlier
−0.1 pts
Peer median
15.9%

Over the twelve months to Sep 26, 2026, Thermo Fisher Scientific kept 14.9% of its revenue as net profit, with an operating margin of 17.9%.

Five years earlier its net margin was 21.9%.

The median for 9 diagnostics and research stocks of a similar size is 15.9%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY202515.0%17.4%40.9%
FY202414.8%17.1%41.3%
FY202314.0%16.0%39.9%
FY202215.5%18.7%42.2%
FY202119.7%25.6%50.1%
FY202019.8%24.2%49.7%
FY201914.5%18.0%44.4%
FY201812.1%15.5%44.6%
FY201710.6%14.2%45.2%
FY201611.1%13.4%45.8%
FY201511.6%13.8%45.7%
FY201411.2%14.8%44.4%
FY20139.7%12.3%42.2%
FY20129.4%11.8%42.3%
FY201111.5%10.8%41.5%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q3 FY2614.9%−0.1 pts17.9%
Q2 FY2615.0%−0.2 pts17.6%
Q1 FY2615.2%−0.0 pts17.5%
Q4 FY2515.0%+0.3 pts17.4%
Q3 FY2515.0%+0.5 pts17.2%
Q2 FY2515.2%+0.5 pts17.1%
Q1 FY2515.2%+1.0 pts17.2%
Q4 FY2414.8%+0.8 pts17.1%
Q3 FY2414.5%+0.8 pts16.9%
Q2 FY2414.7%+1.5 pts17.0%
Q1 FY2414.2%+0.4 pts16.4%
Q4 FY2314.0%−1.5 pts16.0%

Against its peers

Companies in Medical - Diagnostics & Research nearest Thermo Fisher Scientific's size, closest first, today.

CompanyProfit margin
TMOThermo Fisher Scientific14.9%
DHRDanaher15.9%
AAgilent Technologies19.5%
IQVIQVIA8.1%
WATWaters3.6%
IDXXIDEXX Laboratories25.0%
ILMNIllumina18.4%
MTDMettler-Toledo International21.9%
DGXQuest Diagnostics9.2%
LHLabcorp7.0%
Peer median15.9%

Where Thermo Fisher Scientific ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Thermo Fisher Scientific

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.